Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ewelina Madej

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Postepy Biochemii|August 11, 2021
The role of RIPK4 in epidermis physiologyAgnieszka Wolnicka-Głubisz, Ewelina Madej, Anna Lisek
Acta Biochimica Polonica|October 27, 2020
Resveratrol enhances apoptosis induced by the heterocyclic aromatic amines in p53-wt LoVo cells, but not in p53-deficient HaCaT cellsKatarzyna Kuryłowicz, Agnieszka Cierniak, Ewelina Madej, et al.
Cellular Signalling|October 23, 2023
RIPK4 downregulation impairs Wnt3A-stimulated invasiveness via Wnt/β-catenin signaling in melanoma cells and tumor growth in vivoNorbert Wronski, Ewelina Madej, Maja Grabacka, et al.
Biomolecules|January 8, 2025
RIPK4 Downregulation Reduces ABCG2 Expression, Increasing BRAF-Mutated Melanoma Cell Susceptibility to Cisplatin- and Doxorubicin-Induced ApoptosisBartlomiej Olajossy, Norbert Wronski, Ewelina Madej, et al.
International Journal of Molecular Sciences|November 13, 2021
Deciphering the Functional Role of RIPK4 in MelanomaEwelina Madej, Damian Ryszawy, Anna A Brożyna, et al.
Mechanisms of Ageing and Development|November 7, 2017
p38 but not p53 is responsible for UVA-induced MCPIP1 expressionLukasz Skalniak, Marta Smejda, Agnieszka Cierniak, et al.
Journal of Cancer Research and Clinical Oncology|April 24, 2024
The involvement of RIPK4 in TNF-α-stimulated IL-6 and IL-8 production by melanoma cellsEwelina Madej, Anna Lisek, Anna A Brożyna, et al.
Journal of the Mechanical Behavior of Biomedical Materials|December 3, 2014
PDMS substrate stiffness affects the morphology and growth profiles of cancerous prostate and melanoma cellsSzymon Prauzner-Bechcicki, Joanna Raczkowska, Ewelina Madej, et al.
Molecular Oncology|February 9, 2026
RIPK4 function interferes with melanoma cell adhesion and metastasisNorbert Wronski, Sławomir Lasota, Ewelina Madej, et al.
Cancers|February 11, 2023
Vemurafenib and Dabrafenib Downregulates RIPK4 LevelEwelina Madej, Anna A Brożyna, Agnieszka Adamczyk, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Postepy Biochemii|August 11, 2021
The role of RIPK4 in epidermis physiologyAgnieszka Wolnicka-Głubisz, Ewelina Madej, Anna Lisek
Acta Biochimica Polonica|October 27, 2020
Resveratrol enhances apoptosis induced by the heterocyclic aromatic amines in p53-wt LoVo cells, but not in p53-deficient HaCaT cellsKatarzyna Kuryłowicz, Agnieszka Cierniak, Ewelina Madej, et al.
Cellular Signalling|October 23, 2023
RIPK4 downregulation impairs Wnt3A-stimulated invasiveness via Wnt/β-catenin signaling in melanoma cells and tumor growth in vivoNorbert Wronski, Ewelina Madej, Maja Grabacka, et al.
Biomolecules|January 8, 2025
RIPK4 Downregulation Reduces ABCG2 Expression, Increasing BRAF-Mutated Melanoma Cell Susceptibility to Cisplatin- and Doxorubicin-Induced ApoptosisBartlomiej Olajossy, Norbert Wronski, Ewelina Madej, et al.
International Journal of Molecular Sciences|November 13, 2021
Deciphering the Functional Role of RIPK4 in MelanomaEwelina Madej, Damian Ryszawy, Anna A Brożyna, et al.
Mechanisms of Ageing and Development|November 7, 2017
p38 but not p53 is responsible for UVA-induced MCPIP1 expressionLukasz Skalniak, Marta Smejda, Agnieszka Cierniak, et al.
Journal of Cancer Research and Clinical Oncology|April 24, 2024
The involvement of RIPK4 in TNF-α-stimulated IL-6 and IL-8 production by melanoma cellsEwelina Madej, Anna Lisek, Anna A Brożyna, et al.
Journal of the Mechanical Behavior of Biomedical Materials|December 3, 2014
PDMS substrate stiffness affects the morphology and growth profiles of cancerous prostate and melanoma cellsSzymon Prauzner-Bechcicki, Joanna Raczkowska, Ewelina Madej, et al.
Molecular Oncology|February 9, 2026
RIPK4 function interferes with melanoma cell adhesion and metastasisNorbert Wronski, Sławomir Lasota, Ewelina Madej, et al.
Cancers|February 11, 2023
Vemurafenib and Dabrafenib Downregulates RIPK4 LevelEwelina Madej, Anna A Brożyna, Agnieszka Adamczyk, et al.
Pageof 2